Pfizer
-
COVID-19 Vaccine Update: FDA Adds Warning to Moderna and Pfizer Vaccines
-
AstraZeneca COVID-19 Vaccine Protects More Against Delta, Kappa Variants Like Pfizer
-
COVID-19 Vaccine: Study Shows Less Risks of Virus Infection After First Dose, Also for Coronavirus Variants
-
mRNAs Are The Future of Vaccines After Pfizer, Moderna's Success Against COVID—HIV, Cancers Next-in-Line
-
COVID-19 Vaccine Boosters Needed as Early as September With Pfizer. Moderna CEO Aims to Deliver By Year's End
-
New Study Reveals Mixing of AstraZeneca, Pfizer Vaccine is Safe: Will this Mean 'Double Protection' for COVID-19?
-
Pfizer Vaccine Eligibility: 12 to 15 Year Olds to Receive Shots for COVID-19 by Wed, May 12
-
Pfizer COVID-19 Vaccine: 'Extremely Effective' Against UK and South Africa Variants' Harmful Effects, Not a Booster Like Moderna
-
Pfizer Vaccine to be FDA-Authorized for 12 to 15-Year Olds Next Week
-
Pfizer, AstraZeneca Vaccine Side Effects Are Not Too Bad, Study Suggests
-
Pfizer CEO Says COVID-19 Oral Pill Could Arrive At the End of 2021- Powerful Enough to Create 'End-to-End' Treatment Paradigm?
-
US to Gain Leverage on Big Pharma-- Scientist, Developer of Pfizer’s Key Vaccine Tech Says His Reason Behind Joining NIH
Most Popular
